XOMA Royalty to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference

Core Viewpoint - XOMA Royalty Corporation will participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference, highlighting its role as a biotech royalty aggregator and its commitment to improving human health through strategic partnerships [1][3]. Group 1: Event Participation - XOMA's CEO Owen Hughes and CIO Brad Sitko will engage in a fireside chat on February 11, 2025, at 3:20 PM ET [2]. - The presentation will be accessible via a provided link and will also be available on the company's investor relations website for 90 days post-event [2]. Group 2: Company Overview - XOMA Royalty Corporation specializes in acquiring future economic rights associated with therapeutic candidates licensed to pharmaceutical or biotech companies, providing non-dilutive funding to sellers [3]. - The company maintains a growing portfolio of assets, defined as rights to receive potential future economics from underlying therapeutic candidates [3].